Population-based analysis of practices and costs of surveillance for colonic dysplasia in patients with primary sclerosing cholangitis and colitis

Inflammatory Bowel Diseases

Volumn 13, Issue 11, 2007, Pages 1401-1407

  Kaplan, Gilaad G ^a   Heitman, Steven J ^a   Hilsden, Robert J ^a   Urbanski, Stefan ^b   Myers, Robert P ^a   Lee, Samuel S ^a   Burak, Kelly W ^a   Swain, Mark ^a   Panaccione, Remo ^a,b  

^a UNIVERSITY OF CALGARY   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

Author keywords

Incidence; Inflammatory bowel disease; Population based; Primary sclerosing cholangitis; Surveillance colonoscopy

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COLITIS; COLON BIOPSY; COLONOSCOPY; COLORECTAL CANCER; CONTROLLED STUDY; COST BENEFIT ANALYSIS; CROHN DISEASE; DEMOGRAPHY; DISEASE ASSOCIATION; DISEASE SURVEILLANCE; DYSPLASIA; FEMALE; HEALTH CARE COST; HEALTH SURVEY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAGNETIC RESONANCE CHOLANGIOPANCREATOGRAPHY; MALE; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL; ULCERATIVE COLITIS;

ADULT; BIOPSY; CHOLANGITIS, SCLEROSING; COLITIS; COLONOSCOPY; COLORECTAL NEOPLASMS; COSTS AND COST ANALYSIS; FEMALE; HUMANS; MALE; MIDDLE AGED; POPULATION SURVEILLANCE; PRECANCEROUS CONDITIONS;

EID: 36749019677     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1002/ibd.20204     Document Type: Article

References (28)

1. Ekbom A, Helmick C, Zack M, et al. Ulcerative colitis and colorectal cancer. A population-based study. N Engl J Med. 1990;323:1228-1233.
2. Ekbom A, Helmick C, Zack M, et al. Increased risk of large-bowel cancer in Crohn's disease with colonic involvement. Lancet. 1990;336:357-359.
3. Leddin D, Hunt R, Champion M, et al. Canadian Association of Gastroenterology, and the Canadian Digestive Health Foundation: Guidelines on colon cancer screening. Can J Gastroenterol. 2004;18:93-99.
4. Eaden JA, Mayberry JF. Guidelines for screening and surveillance of asymptomatic colorectal cancer in patients with inflammatory bowel disease. Gut. 2002;51(Suppl 5):V10-V12.
5. Winawer S, Fletcher R, Rex D, et al. Colorectal cancer screening and surveillance: clinical guidelines and rationale - update based on new evidence. Gastroenterology. 2003;124:544-560.
6. Soetikno RM, Lin OS, Heidenreich PA, et al. Increased risk of colorectal neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis: a meta-analysis. Gastrointest Endosc. 2002;56:48-54.
7. Broome U, Lofberg R, Veress B, et al. Primary sclerosing cholangitis and ulcerative colitis: evidence for increased neoplastic potential. Hepatology. 1995;22:1404-1408.
8. Brentnall TA, Haggitt RC, Rabinovitch PS, et al. Risk and natural history of colonic neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis. Gastroenterology. 1996;110:331-338.
9. Bansal P, Sonnenberg A. Risk factors of colorectal cancer in inflammatory bowel disease. Am J Gastroenterol. 1996;91:44-48.
10. Shetty K, Rybicki L, Brzezinski A, et al. The risk for cancer or dysplasia in ulcerative colitis patients with primary sclerosing cholangitis. Am J Gastroenterol. 1999;94:1643-1649.
11. Marchesa P, Lashner BA, Lavery IC, et al. The risk of cancer and dysplasia among ulcerative colitis patients with primary sclerosing cholangitis. Am J Gastroenterol. 1997;92:1285-1288.
12. Leidenius MH, Farkkila MA, Karkkainen P, et al. Colorectal dysplasia and carcinoma in patients with ulcerative colitis and primary sclerosing cholangitis. Scand J Gastroenterol. 1997;32:706-711.
13. Kornfeld D, Ekbom A, Ihre T. Is there an excess risk for colorectal cancer in patients with ulcerative colitis and concomitant primary sclerosing cholangitis? A population based study. Gut. 1997;41:522-525.
14. Eaden J. Review article: colorectal carcinoma and inflammatory bowel disease. Aliment Pharmacol Ther. 2004;20(Suppl 4):24-30.
15. Itzkowitz SH, Harpaz N. Diagnosis and management of dysplasia in patients with inflammatory bowel diseases. Gastroenterology. 2004;126:1634-1648.
16. Calgary Health Region. Hospital and Community Health Care Sites. Available at: http://www.calgaryhealthregion.ca/hospital/index.html. Accessed January 18, 2007.
17. Statistics Canada. 2001 Community Profiles. Available at: http://www.12.statcan.ca/english/Profil01/CP01/Index.cfm?Lang=E. Accessed January 18, 2007.
18. Lee YM, Kaplan MM. Primary sclerosing cholangitis. N Engl J Med. 1995;332:924-933.
19. Bjornsson E, Boberg KM, Cullen S, et al. Patients with small duct primary sclerosing cholangitis have a favourable long term prognosis. Gut. 2002;51:731-735.
20. Olsson R, Danielsson A, Jarnerot G, et al. Prevalence of primary sclerosing cholangitis in patients with ulcerative colitis. Gastroenterology. 1991;100:1319-1323.
21. Lennard-Jones JE. Classification of inflammatory bowel disease. Scand J Gastroenterol Suppl. 1989;170:2-6; discussion 16-19.
22. Rubin CE, Haggitt RC, Burmer GC, et al. DNA aneuploidy in colonic biopsies predicts future development of dysplasia in ulcerative colitis. Gastroenterology. 1992;103:1611-1620.
23. Riddell RH, Goldman H, Ransohoff DF, et al. Dysplasia in inflammatory bowel disease: standardized classification with provisional clinical applications. Hum Pathol. 1983;14:931-968.
24. Heitman SJ, Manns BJ, Hilsden RJ, et al. Cost-effectiveness of computerized tomographic colonography versus colonoscopy for colorectal cancer screening. CMAJ. 2005;173:877-881.
25. Bernstein CN, Weinstein WM, Levine DS, et al. Physicians' perceptions of dysplasia and approaches to surveillance colonoscopy in ulcerative colitis. Am J Gastroenterol. 1995;90:2106-2114.
26. Eaden JA, Ward BA, Mayberry JF. How gastroenterologists screen for colonic cancer in ulcerative colitis: an analysis of performance. Gastrointest Endosc. 2000;51:123-128.
27. Reddy SI, Friedman S, Telford JJ, et al. Are patients with inflammatory bowel disease receiving optimal care? Am J Gastroenterol. 2005;100:1357-1361.
28. Kavic SM, Basson MD. Complications of endoscopy. Am J Gastroenterol. 2001;181:319-332.